Motivational Interviewing for Gun Violence Prevention
(SHIFT Trial)
Trial Summary
What is the purpose of this trial?
This study is a quasi-experimental design, specifically a non-randomized controlled trial (NCT) designed to test the effects of gun violence reduction intervention including MI for youth ages 16-24 years old who present to the Emergency Department or ICU Spirit of Charity Trauma Center (SCTC) at University Medical Centers or another area hospital in New Orleans, Louisiana following a gunshot injury or stab wound. The study will utilize an enrollment strategy that involves alternating, across recruitment days, the assigned study condition. Thus, Day 1 participants would be enrolled into TAU, Day 2 participants would be enrolled in MI-case management condition, Day 3 participants would be enrolled in TAU, etc. This proposed design will minimize any confounds associated with self-selection while possibly increasing enrollment rate. Research questions include: 1. Will youth allocated to the MI prevention condition have safer firearm related behaviors and beliefs compared to the TAU control condition at 6 months post- enrollment? 2. Will youth allocated to the MI prevention condition have reduced gun violence recidivism compared to the TAU control condition at 18 months post-enrollment. 3. How do youth's social and normative environments influence their gun behaviors and attitudes? Researchers will compare intervention and TAU arms to see if there are any differences in outcome measures. Participants will: 1. complete study eligibility assessment, be assigned to one of two conditions depending on the date of assessment, consent, and enroll in the Emergency Department (ED) or inpatient unit of hospital by a study team member, 2. participate in one of two conditions: MI administered by a licensed clinical social worker, or treatment as usual control group (TAU) administered by a study team member (n=170 per condition) 3. complete three surveys (baseline, 3-month, and 6-month) conducted by a study team member 4. 18-month post examination of participant hospital records 5. have the option to complete a 1-1.5 hour interview, 1-3 months after the 6-month survey is completed (n=50)
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your healthcare provider.
What data supports the effectiveness of the treatment Motivational Interviewing and Firearm Safety Training for gun violence prevention?
Motivational Interviewing (MI) has been shown to be effective in helping people change behaviors, such as reducing drug and alcohol use, by encouraging them to talk about their own reasons for change. This approach has been successfully used in various settings, including health-related behavior changes and psychiatric disorders, suggesting it could be beneficial for gun violence prevention by addressing ambivalence and promoting safer behaviors.12345
Is Motivational Interviewing generally safe for humans?
How is the treatment Motivational Interviewing and Firearm Safety Training different from other treatments for gun violence prevention?
Motivational Interviewing (MI) is unique because it focuses on helping individuals explore and resolve their mixed feelings about changing behaviors, which can lead to more effective prevention of gun violence. Unlike other treatments, MI involves a collaborative conversation style that encourages individuals to talk themselves into making positive changes, making it particularly effective for behavior change.3471011
Research Team
Julia M Fleckman, PhD, MPH
Principal Investigator
Tulane University
Eligibility Criteria
This trial is for youth aged 14-24 who have been admitted to the Emergency Department or ICU at SCTC in New Orleans, Louisiana after a gunshot injury or stab wound. Participants must be willing to undergo motivational interviewing and firearm safety training with case management, complete surveys, and allow hospital record review.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Enrollment and Initial Assessment
Participants complete study eligibility assessment, are assigned to one of two conditions, consent, and enroll in the Emergency Department or inpatient unit of the hospital
Treatment
Participants receive either Motivational Interviewing with case management and firearm safety training or Treatment as Usual
Follow-up
Participants complete surveys and are monitored for changes in firearm-related behaviors and beliefs
Qualitative Interview (Optional)
Participants have the option to complete a 1-1.5 hour interview to gain in-depth understanding of social and normative environments
Treatment Details
Interventions
- Motivational Interviewing and Firearm Safety Training (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
James Zanewicz
Tulane University
Chief Medical Officer
MD from Tulane University
Elaine Hamm
Tulane University
Chief Executive Officer since 2022
PhD in Microbiology from the University of Oklahoma
Centers for Disease Control and Prevention
Collaborator
Dr. Debra Houry
Centers for Disease Control and Prevention
Chief Medical Officer
MD, MPH
Dr. Susan Monarez
Centers for Disease Control and Prevention
Chief Executive Officer
PhD